DK3091005T3 - 1,2-naphthoquinonderivat og fremgangsmåde til fremstilling deraf - Google Patents
1,2-naphthoquinonderivat og fremgangsmåde til fremstilling deraf Download PDFInfo
- Publication number
- DK3091005T3 DK3091005T3 DK14877254.4T DK14877254T DK3091005T3 DK 3091005 T3 DK3091005 T3 DK 3091005T3 DK 14877254 T DK14877254 T DK 14877254T DK 3091005 T3 DK3091005 T3 DK 3091005T3
- Authority
- DK
- Denmark
- Prior art keywords
- naphthoquinon
- derivatives
- preparation
- naphthoquinon derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20130166912 | 2013-12-30 | ||
| PCT/KR2014/013038 WO2015102369A1 (ko) | 2013-12-30 | 2014-12-30 | 1,2 나프토퀴논 유도체 및 이의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3091005T3 true DK3091005T3 (da) | 2020-12-21 |
Family
ID=53493651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14877254.4T DK3091005T3 (da) | 2013-12-30 | 2014-12-30 | 1,2-naphthoquinonderivat og fremgangsmåde til fremstilling deraf |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10927085B2 (da) |
| EP (1) | EP3091005B1 (da) |
| JP (1) | JP6903266B2 (da) |
| KR (1) | KR101739362B1 (da) |
| CN (1) | CN106103417B (da) |
| AU (1) | AU2014374601B2 (da) |
| CA (1) | CA2935319C (da) |
| DK (1) | DK3091005T3 (da) |
| PL (1) | PL3091005T3 (da) |
| WO (1) | WO2015102369A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105130936B (zh) * | 2015-09-01 | 2017-09-26 | 中国药科大学 | 一类邻萘醌化合物、其制备方法和医药用途 |
| KR20190118119A (ko) | 2018-04-09 | 2019-10-17 | 주식회사 휴엔 | 1,2-나프토퀴논 유도체 화합물을 포함하는 고형암 또는 혈액암의 예방 또는 치료용 약학 조성물 |
| KR20190118118A (ko) | 2018-04-09 | 2019-10-17 | 영진약품 주식회사 | 1,2-나프토퀴논 유도체 화합물을 포함하는 고형암 또는 혈액암의 예방 또는 치료용 약학 조성물 |
| KR102247694B1 (ko) | 2019-05-31 | 2021-05-03 | 주식회사 엘마이토테라퓨틱스 | 나프토퀴논 또는 벤조인다졸 화합물을 유효성분으로 포함하는 염증성 질환 치료용 약학적 조성물 |
| CN111559991B (zh) * | 2020-06-01 | 2022-01-25 | 河南省锐达医药科技有限公司 | 一种萘胺类化合物及其盐的制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080047959A (ko) | 2006-11-27 | 2008-05-30 | 주식회사 엠디바이오알파 | 비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 나프토퀴논계 약제조성물 |
| KR101468449B1 (ko) | 2007-04-26 | 2014-12-04 | 주식회사 케이티앤지생명과학 | 신규한 페난스렌퀴논계 화합물 및 이를 포함하는대사증후군 질환의 치료 또는 예방용 약제 조성물 |
-
2014
- 2014-12-30 CN CN201480071786.4A patent/CN106103417B/zh active Active
- 2014-12-30 CA CA2935319A patent/CA2935319C/en active Active
- 2014-12-30 EP EP14877254.4A patent/EP3091005B1/en active Active
- 2014-12-30 JP JP2016544574A patent/JP6903266B2/ja active Active
- 2014-12-30 AU AU2014374601A patent/AU2014374601B2/en active Active
- 2014-12-30 KR KR1020140193306A patent/KR101739362B1/ko active IP Right Grant
- 2014-12-30 US US15/102,974 patent/US10927085B2/en active Active
- 2014-12-30 DK DK14877254.4T patent/DK3091005T3/da active
- 2014-12-30 WO PCT/KR2014/013038 patent/WO2015102369A1/ko active Application Filing
- 2014-12-30 PL PL14877254T patent/PL3091005T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6903266B2 (ja) | 2021-07-14 |
| WO2015102369A1 (ko) | 2015-07-09 |
| EP3091005A4 (en) | 2017-05-17 |
| CN106103417A (zh) | 2016-11-09 |
| EP3091005A1 (en) | 2016-11-09 |
| PL3091005T3 (pl) | 2021-04-19 |
| AU2014374601A1 (en) | 2016-06-30 |
| US20160376243A1 (en) | 2016-12-29 |
| US10927085B2 (en) | 2021-02-23 |
| CA2935319C (en) | 2022-07-19 |
| JP2017501204A (ja) | 2017-01-12 |
| KR101739362B1 (ko) | 2017-06-09 |
| EP3091005B1 (en) | 2020-11-11 |
| CA2935319A1 (en) | 2015-07-09 |
| CN106103417B (zh) | 2019-08-06 |
| KR20150080425A (ko) | 2015-07-09 |
| AU2014374601B2 (en) | 2019-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3019200T3 (da) | Oligonukleotid-ligand-konjugater og fremgangsmåde til fremstiling deraf | |
| DK3354649T3 (da) | Oxaspiroderivat, fremstillingsmetode derfor og anvendelser deraf i lægemidler | |
| DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
| DK3559000T3 (da) | Benzimidazol-derivater, fremgangsmåder til fremstilling og anvendelser deraf | |
| DK3406633T3 (da) | Multispecifikke antistoffer, multispecifikke aktiverbare antistoffer og fremgangsmåder til anvendelse heraf | |
| DK3009021T3 (da) | Handske og fremgangsmåde til fremstilling deraf | |
| DK3079719T3 (da) | ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3065771T3 (da) | Fremgangsmåder og sammensætninger til vedvarende immunterapi | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| DK3050883T3 (da) | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter | |
| DK3086807T3 (da) | Antistoffer og fremgangsmåder til anvendelse | |
| BR112016017742A2 (pt) | composição e método auxiliares do sono | |
| DK3022361T4 (da) | Rambuk og fremgangsmåde til anvendelse deraf | |
| DK3025113T3 (da) | Entalpivekslerelement og fremgangsmåde til fremstilling heraf | |
| DK2958926T3 (da) | Epidithiodioxopiperazinforbindelse eller derivater deraf og anvendelse deraf | |
| DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
| BR112015019224A2 (pt) | aparelho, e método | |
| PT3064498T (pt) | Derivados de pirazolopirimidona ou de pirrolotriazona, método de preparação dos mesmos, e aplicações farmacêuticas dos mesmos | |
| DK3398598T3 (da) | Sulfonamidderivat og fremstillingsmetode og anvendelse deraf | |
| DK3066089T3 (da) | Substituerede n-acetyl-l-cysteinderivater og relaterede forbindelser | |
| DK3035957T3 (da) | Bakteriel vaccine og fremgangsmåde til fremstilling deraf | |
| DK3038656T3 (da) | Forbindelse af glycosaminoglycan, fremgangsmåde til fremstilling og anvendelse deraf | |
| DK3025108T3 (da) | Entalpivekslerelement og fremgangsmåde til fremstilling heraf | |
| DK3386956T3 (da) | Fumagillolderivater og polymorfer deraf | |
| DK3091005T3 (da) | 1,2-naphthoquinonderivat og fremgangsmåde til fremstilling deraf |